Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

3 Stocks Under $50 Walking a Fine Line

December 24, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 8% in the afternoon session after an analyst at Mizuho raised the firm's price target on the stock while maintaining a Neutral...

Why Fortrea (FTRE) Stock Is Up Today

December 19, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 5.7% in the morning session after an analyst at Mizuho raised the company's price target. Analyst Ann Hynes reaffirmed a...

Topics Initial Public Offering

Why Fortrea (FTRE) Stock Is Trading Up Today

December 18, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf

Topics Initial Public Offering

December 16, 2025

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

December 12, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 6.2% in the afternoon session after Citigroup upgraded the stock's rating to Buy from Neutral and significantly raised its...

Why Fortrea (FTRE) Stock Is Up Today

December 11, 2025

Important Notice to Long-Term Shareholders of Alexandria Real Estate Equities, Inc. (NYSE: ARE); CarMax, Inc. (NYSE: KMX); Fortrea Holdings, Inc. (NASDAQ: FTRE); StubHub Holdings, Inc. (NYSE: STUB): Grabar Law Office Investigates Claims on Your Behalf

Topics Artificial Intelligence Initial Public Offering

December 11, 2025

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

December 10, 2025

Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

December 08, 2025

SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery

December 04, 2025

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims

December 02, 2025

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf

December 01, 2025

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Inspire Medical Systems, Inc. (NYSE: INSP); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on

November 26, 2025

Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 10.2% in the afternoon session after the company announced it completed a debt tender offer, purchasing approximately $75.7...

Fortrea (FTRE) Stock Trades Up, Here Is Why

November 25, 2025

Topics Artificial Intelligence Government Initial Public Offering

Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences

November 25, 2025

BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government...

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and Stride, Inc. (NYSE: LRN): Grabar Law Office is Investigating Claims on Your Behalf

Topics Economy Government

November 24, 2025

Attention Long-Term Shareholders of Fortrea Holdings, Inc. (NASDAQ: FTRE); enCore Energy Corp. (NASDAQ: EU); Humana Inc. (NYSE: HUM); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

November 24, 2025

Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand

November 24, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know

November 21, 2025

Attention Long-Term Shareholders of Fortrea Holdings, Inc. (NASDAQ: FTRE); Humana Inc. (NYSE: HUM); Stride Inc. (NYSE: LRN); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

Topics Artificial Intelligence Economy Stocks

November 21, 2025

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); enCore Energy Corp. (NASDAQ: EU); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Stride, Inc. (NYSE: LRN): Grabar Law Office Investigates Claims on Your Behalf

November 20, 2025

November 19, 2025

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); enCore Energy Corp. (NASDAQ: EU); Fluor Corporation (NYSE: FLR); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating

November 18, 2025

Important Notice to Long-Term Shareholders of enCore Energy Corp. (NASDAQ: EU); Fluor Corporation (NYSE: FLR); Fortrea Holdings, Inc. (NASDAQ: FTRE); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf

November 17, 2025

Fortrea Appoints Agnieszka Gallagher as General Counsel

November 17, 2025

November 15, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

1 Healthcare Stock to Consider Right Now and 2 Facing Headwinds

November 13, 2025

Fortrea’s third quarter results were met with a significant positive response from the market, as robust demand across its clinical pharmacology and clinical development businesses drove revenue...

Topics Stocks

5 Insightful Analyst Questions From Fortrea’s Q3 Earnings Call

November 12, 2025